Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Chembiochem : a European Journal of Chemical Biology|July 10, 2003
Acceptor specificity and inhibition of the bacterial cell-wall glycosyltransferase MurGHaitian Liu, Thomas K Ritter, Reiko Sadamoto, et al.Journal of the American Chemical Society|August 1, 2002
Cell-wall engineering of living bacteriaReiko Sadamoto, Kenichi Niikura, Pamela S Sears, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2012
Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strainLaurica A Petrella, Susan P Sambol, Adam Cheknis, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2011
Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infectionsKathleen M Mullane, Mark A Miller, Karl Weiss, et al.The Pediatric Infectious Disease Journal|January 4, 2021
Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate From a Randomized Phase 3 Trial in Adolescents With Acute Bacterial Skin and Skin Structure InfectionsJohn S Bradley, Tinatin Antadze, Borislav Ninov, et al.Antimicrobial Agents and Chemotherapy|September 13, 2021
Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure InfectionsDan Li, Philip E Sabato, Benjamin Guiastrennec, et al.The Pediatric Infectious Disease Journal|March 12, 2021
Pharmacokinetics and Safety of Single-dose Tedizolid Phosphate in Children 2 to <12 Years of AgeAntonio C Arrieta, Jocelyn Y Ang, Claudia Espinosa, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2018
A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell TransplantationKathleen M Mullane, Drew J Winston, Ajay Nooka, et al.The Journal of Infection|September 10, 2023
Molnupiravir for intra-household prevention of COVID-19: The MOVe-AHEAD randomized, placebo-controlled trialSady A Alpizar, Jose Accini, Duane C Anderson, et al.Pageof 1